BioFreedom QCA Study in CAD Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 200 participants.
Also called NCT03307213
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT03307213
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Denmark, Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT03307213. Randomized; single masking; primary purpose treatment. Start 2018-06-19 (actual); primary completion 2019-09-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BioFreedom QCA Study in CAD Patients
- Acronym
- BioFreedomQCA
- Condition
- Coronary Artery Disease
- Condition
- Cardiac Death
- Condition
- Myocardial Infarction
- Intervention (Device)
- BioFreedom™ CoCr Biolimus A9™ stent
- Intervention (Device)
- BioFreedom™ SS Biolimus A9™ stent
- Lead sponsor
- Biosensors Europe SA
Record details
- Record id
cardio:ct-nct03307213- Content hash
9c8d59d57178ddc38758468a92d3dffc3b34f344ecf245ea4711a0526d97057c